LOGC LogicBio Therapeutics, Inc.

OTC
$12.62

LogicBio Therapeutics, Inc. (LOGC) Institutional Ownership

What the institutions did with LOGC last quarter, from their 13F filings. Counting managers rather than shares is the point: a single index fund adding to a position tells you far less than four hundred separate managers all deciding to. Positions as reported for the quarter ended June 30, 2026.

Managers reporting
4
filed a 13F this quarter
Managers holding
4
+1 on the quarter
Buyers
2
1 opened new
Sellers
0
0 sold out entirely
Buyer share
100.0%
of managers who traded it
Breadth
+100.0
net buyers, as a share of those trading

Only 4 managers reported a position this quarter, so the percentages above describe a very small sample.

Every manager below opens. Subscribers can see any firm's whole portfolio — every position, its weight, and what they bought, trimmed and exited last quarter.

Sign in or subscribe

Largest holders

Manager Shares % of reported
MASON CAPITAL MANAGEMENT LLC 291.3K 99.6%
OAKWORTH CAPITAL, INC. 624 0.2%
GAMMA Investing LLC 525 0.2%
KELLEHER FINANCIAL ADVISORS 134 0.0%

Largest changes

Manager Action Previous Current Change
MASON CAPITAL MANAGEMENT LLC New 0 291.3K +291.3K
KELLEHER FINANCIAL ADVISORS Increased 67 134 +67

13F filings are due 45 days after quarter end and cover long positions in U.S.-listed equities only, so this is a lagged and partial picture: shorts, bonds and foreign listings never appear. Options positions are excluded here rather than folded into the share counts. Political ownership is coming.